Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Ruipeng Pet Healthcare Group is a China-based veterinary healthcare and pet services company operating a large network of pet hospitals and referral centers. The group focuses on companion animal medical care, diagnostics, specialty services, grooming, boarding, and related pet products and services. It has also built digital and operational infrastructure including telemedicine, intelligent microscopy, and a clinical decision support system to support hospital operations and veterinary care. Beyond clinical services, the company participates in veterinary education, supply chain services, and pet industry ecosystem development. Ruipeng is best understood as a commercial veterinary services platform rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ruipeng Pet Hospital.